Long-term subcutaneous administration of apomorphine or insulin for Parkinson's disease or diabetes and skin event rates

被引:0
|
作者
Wells, K. [5 ]
Zhou, S. [1 ]
Engelhard, J. [6 ]
Oleske, D. [2 ]
Werner, B. [3 ]
Facheris, M. [2 ]
Zamudio, J. [4 ]
机构
[1] IQVIA, Fairfax, VA USA
[2] Global Epidemiol, N Chicago, IL USA
[3] Team Gesundheit GmbH, Essen, Germany
[4] AbbVie, Mettawa, IL USA
[5] MedSci, Durham, NC USA
[6] IQVIA, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO-121
引用
收藏
页码:515 / 515
页数:1
相关论文
共 50 条
  • [31] Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study
    Meira, Bruna
    Degos, Bertrand
    Corsetti, Elise
    Doulazmi, Mohamed
    Berthelot, Emeline
    Virbel-Fleischman, Clara
    Dodet, Pauline
    Meneret, Aurelie
    Mariani, Louise-Laure
    Delorme, Cecile
    Cormier-Dequaire, Florence
    Bendetowicz, David
    Villain, Nicolas
    Tarrano, Clement
    Mantisi, Lise
    Letrillart, Helene
    Louapre, Celine
    McGovern, Eavan
    Worbe, Yulia
    Grabli, David
    Vidailhet, Marie
    Hainque, Elodie
    Roze, Emmanuel
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [32] Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
    Bruna Meira
    Bertrand Degos
    Elise Corsetti
    Mohamed Doulazmi
    Emeline Berthelot
    Clara Virbel-Fleischman
    Pauline Dodet
    Aurélie Méneret
    Louise-Laure Mariani
    Cécile Delorme
    Florence Cormier-Dequaire
    David Bendetowicz
    Nicolas Villain
    Clément Tarrano
    Lise Mantisi
    Hélène Letrillart
    Céline Louapre
    Eavan McGovern
    Yulia Worbe
    David Grabli
    Marie Vidailhet
    Elodie Hainque
    Emmanuel Roze
    npj Parkinson's Disease, 7
  • [33] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [35] Continuous Subcutaneous Apomorphine Infusion for Parkinson Disease Motor Fluctuations: Long-term Data from the Ongoing InfusON Extension Study
    LeWitt, P.
    Isaacson, S.
    Espay, A.
    Reyes, S.
    Formella, A.
    Ceresoli-Borroni, G.
    MOVEMENT DISORDERS, 2024, 39 : S348 - S349
  • [36] Long-term course of Parkinson's disease
    Ebersbach, G.
    NERVENHEILKUNDE, 2010, 29 (06) : 345 - 350
  • [37] Ventricular Bigeminy after Subcutaneous Administration of Apomorphine in a Patient with Refractory Parkinson's Disease: A Case Report
    Kaminioti, Anastasia N.
    Nikitas, Georgios T.
    Terlis, Apostolos K.
    Manolis, Athanasios G.
    Thomaidesa, Thomas
    Panousopoulou, Aggeliki N.
    JOURNAL OF MOVEMENT DISORDERS, 2013, 6 (01) : 9 - 12
  • [38] Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
    Peter Hagell
    Arja Höglund
    Carina Hellqvist
    Eva-Lena Johansson
    Berit Löwed
    Anne-Christine Sjöström
    Carina Karlberg
    Margareth Lundgren
    Nil Dizdar
    Anders Johansson
    Thomas Willows
    Johan Rådberg
    Filip Bergquist
    Journal of Neurology, 2020, 267 : 3411 - 3417
  • [39] Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease
    Hagell, Peter
    Hoglund, Arja
    Hellqvist, Carina
    Johansson, Eva-Lena
    Lowed, Berit
    Sjostrom, Anne-Christine
    Karlberg, Carina
    Lundgren, Margareth
    Dizdar, Nil
    Johansson, Anders
    Willows, Thomas
    Radberg, Johan
    Bergquist, Filip
    JOURNAL OF NEUROLOGY, 2020, 267 (11) : 3411 - 3417
  • [40] APOMORPHINE SUBLINGUAL FILM DOES NOT WORSEN DYSKINESIA IN THE LONG-TERM TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Klos, K. J.
    Hui, J. S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 42